Rhamnogalacturonan II (RG-II, see Figure 1), a component of pectin that can be produced through bacterial fermentation, showed a preventive effect against lymphoma by increasing the DC-based immune response through the toll-like receptor 4 (TLR4) signaling pathway. The gene discussed is TLR4; the disease is lymphoma.